Please try another search
For the fiscal year ended 31 December 2008, CellKinetics Ltd revenues increased from $0K to $21K. Net lossincreased 14% to $2.4M. Revenues reflect an increase indemand for the Company's products and services due tofavorable market conditions. Higher net loss reflectsResearch and development costs increase of 1% to $1.2M(expense). Basic Earnings per Share excluding ExtraordinaryItems increased from -$0.13 to -$0.12.
Period Ending: | Dec 31, 2008 | Dec 31, 2007 | Dec 31, 2006 | Dec 31, 2005 |
---|---|---|---|---|
Total Revenue | 0.02 | 0 | 0 | 0 |
Gross Profit | 0.01 | 0 | 0 | |
Operating Income | -2.4 | -2.08 | -1.78 | -1.75 |
Net Income | -2.38 | -2.1 | -1.81 | -1.77 |
Period Ending: | Dec 31, 2008 | Dec 31, 2007 | Dec 31, 2006 | Dec 31, 2005 |
---|---|---|---|---|
Total Assets | 3.49 | 2.93 | 2.71 | |
Total Liabilities | 2.36 | 0.89 | 0.62 | |
Total Equity | 1.13 | 2.04 | 2.08 |
Period Ending: | Dec 31, 2008 | Dec 31, 2007 | Dec 31, 2006 | Dec 31, 2005 |
---|---|---|---|---|
Period Length: | 12 Months | 12 Months | 12 Months | 12 Months |
Cash From Operating Activities | -2.27 | -1.72 | -1.68 | -1.49 |
Cash From Investing Activities | -0.03 | -0.1 | -0.02 | -0.04 |
Cash From Financing Activities | 3.35 | 1.8 | 1.72 | 1.53 |
Net Change in Cash | 1.05 | -0.01 | 0.02 | 0 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review